Overview
Status
Active
Registry date
2021-05-28
Share capital
50 000,00 PLN
Registered address
ul. Chmielna 2, 95-054 Wola Zaradzyńska, Poland
Electronic delivery address
AE:PL-10725-51126-AEWVD-24
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 9.00mMedianUSD 873.84kAverageUSD 20.03m
Net profit
This companyUSD 505.88kMedianUSD 28.21kAverageUSD 815.54k
Operating costs
This companyUSD 8.31mMedianUSD 801.08kAverageUSD 18.78m
Assets
This companyUSD 1.08mMedianUSD 539.29kAverageUSD 10.66m
Industry
Bank accounts
Registered as a VAT taxpayer on 2021-06-23. Active
68 1600 1462 1858 7527 3000 0001
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Authorized Representatives
Łukasz Piotr Szymański — Management Board Member
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Mieczysław Antoni Martynowski (54) | 10 | $1,350.62 | 10% |
Łukasz Piotr Szymański (45) | 90 | $12,155.59 | 90% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Łukasz Piotr Szymański (45) | Shareholder of a joint-stock company, 90.0% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Ana-Medsp. z o.o. | $5,202,905.16 | ana-med.eu | ||
| TDFS.A. | $5,168,316.22 | tdfsa.pl | ||
| OMET Medicalsp. z o.o. | $1,867,545.06 | ometmedical.pl | ||
| Cytogen - Polskasp. z o.o. | $1,127,200.51 | cytogen.com.pl | ||
| Goldfarmexsp. z o.o. | $710,510.28 | goldfarmex.pl | ||
| Orthoactivesp. z o.o. | $617,449.08 | orthoactive.pl | ||
| Tecnobody Polskasp. z o.o. | $508,641.92 | mtt.net.pl | ||
| CanpolandS.A. | $328,824.15 | canpoland.com | ||
| Geneco Groupsp. z o.o. | $156,220.50 | genecocontact.pl | ||
| Novaova Sosnowski Wadowskisp. k. | $54,452.69 | novaova.pl |
FAQ
The main business activity of Optivet focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on May 28, 2021.
The headquarters is located at: ul. Chmielna 2, 95-054 Wola Zaradzyńska.
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $3,239,142, representing an increase of 110.3% compared to 2023.
Yes, the company recorded a net profit of $66,591 in 2024, meaning the company increased its profit by 107.6%.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to $2,889,854 in 2024, representing 92% of all operating expenses.
Last updated: 2026-04-27